These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8983800

  • 21. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.
    Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
    [Abstract] [Full Text] [Related]

  • 22. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
    Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A.
    Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340
    [Abstract] [Full Text] [Related]

  • 23. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
    Pachioli R, Genova R.
    Pediatrics; 1971 Apr; 47(4):731-6. PubMed ID: 4326172
    [No Abstract] [Full Text] [Related]

  • 24. [Clinico-morphologic heterogeneity of minimal changes in glomerulonephritis].
    Shestakova LA, Varshavskiĭ VA.
    Arkh Patol; 1994 Apr; 56(6):22-8. PubMed ID: 7605213
    [Abstract] [Full Text] [Related]

  • 25. [Clinico-morphologic correlations in functionally compensated chronic glomerulonephritis].
    Ratner MIa, Serov VV.
    Klin Med (Mosk); 1989 Jun; 67(6):46-51. PubMed ID: 2779154
    [No Abstract] [Full Text] [Related]

  • 26. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K, Ito H, Anzai M, Matsumura C, Kurayama H.
    J Nephrol; 2013 Jun; 26(2):306-14. PubMed ID: 22641570
    [Abstract] [Full Text] [Related]

  • 27. [Minimal change glomerulonephritis, diffuse mesangioproliferative glomerulonephritis and focal and segmental glomerular sclerosis and hyalinosis].
    Belovezhdov N.
    Vutr Boles; 1984 Jun; 23(4):42-6. PubMed ID: 6506660
    [Abstract] [Full Text] [Related]

  • 28. [Focal segmental glomerular hyalinosis: a special form of fibroplastic glomerulonephritis].
    Serov VV, Kupriianova LA, Varshavskiĭ VA, Pal'tsev MA, Nikolaev AIu.
    Arkh Patol; 1982 Jun; 44(7):24-9. PubMed ID: 7125935
    [Abstract] [Full Text] [Related]

  • 29. Morphological transition in minimal change nephrotic syndrome.
    Tejani A.
    Nephron; 1985 Jun; 39(3):157-9. PubMed ID: 3974779
    [No Abstract] [Full Text] [Related]

  • 30. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ.
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [Abstract] [Full Text] [Related]

  • 31. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 32. Ciclosporin in the treatment of nephrosis. Minimal change disease and focal-segmental glomerulosclerosis.
    Meyrier A.
    Am J Nephrol; 1989 Sep; 9 Suppl 1():65-71. PubMed ID: 2646928
    [No Abstract] [Full Text] [Related]

  • 33. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 34. [Focal glomerular sclerosis].
    Belovezhdov M, Neshev Kh.
    Vutr Boles; 1977 Oct; 16(4):14-8. PubMed ID: 335660
    [No Abstract] [Full Text] [Related]

  • 35. [The catamnesis of patients with the minimal change nephrotic syndrome--lipoid nephrosis].
    Papaian AV, Savenkova ND, Val'kovich EI.
    Pediatriia; 1990 Oct; (9):19-23. PubMed ID: 2259595
    [Abstract] [Full Text] [Related]

  • 36. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A, Dial C, Ka EF, Lèye A, Pouye A, Ka MM, Mbengue M, Droz D, Diouf B.
    Dakar Med; 2008 Oct; 53(1):45-51. PubMed ID: 19102117
    [Abstract] [Full Text] [Related]

  • 37. Renal biopsy in Saudi children with nephrotic syndrome not responsive to corticosteroid: a preliminary report.
    Abdurrahman MB, el-Idrissy AT, Hafeez MA, Wright EA, Omar SA.
    Trop Geogr Med; 1986 Jun; 38(2):141-5. PubMed ID: 3526671
    [Abstract] [Full Text] [Related]

  • 38. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C, Banfi G, Imbasciati E, Tarantino A.
    Contrib Nephrol; 1982 Jun; (34):33-54. PubMed ID: 6293765
    [No Abstract] [Full Text] [Related]

  • 39. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C, Passerini P.
    Clin Nephrol; 1991 Jun; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [Abstract] [Full Text] [Related]

  • 40. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J.
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.